Abstract
Bone marrow (BM)-derived mesenchymal stem cells (MSCs) have been implicated in tumor progression, making MSCs important targets for anti-cancer strategies. In this study, we show that MSCs promote tumor growth in vivo in a lymphoma xenograft model. We show that MSCs provide direct cell-cell contact interactions and, to a lesser extend, soluble factors that promote tumor cell proliferation and survival in vitro. PTK787/ZK 222584 reduces tumor growth-promoting effects of MSCs both in vitro and in vivo. Our results address the importance of targeting the MSCs for future anti-cancer strategies.
Original language | English |
---|---|
Pages (from-to) | 526-534 |
Number of pages | 9 |
Journal | Cancer Investigation |
Volume | 28 |
Issue number | 5 |
DOIs | |
Publication status | Published - Jun-2010 |
Keywords
- Mesenchymal stem cells
- Tumor growth
- Angiogenesis
- Vessel density
- Proliferation
- Apoptosis
- PTK787/ZK 222584
- MARROW STROMAL CELLS
- VERSUS-HOST-DISEASE
- GROWTH-FACTOR
- VIVO
- DIFFERENTIATE
- APOPTOSIS
- LYMPHOMA
- LINES